Menu
GWAS Study

Genome-Wide Association Study of Quantitative Kidney Function in 52,531 Individuals with Diabetes Identifies Five Diabetes-Specific Loci.

Cole JB, Dahlström EH, Fermin D et al.

40323663 PubMed ID
GWAS Study Type
5064 Participants
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

CJ
Cole JB
DE
Dahlström EH
FD
Fermin D
GY
Gupta Y
HC
Hill C
SL
Smyth LJ
LH
Liu H
KR
Kreienkamp RJ
PM
Pezzolesi MG
CJ
Cao JJ
VE
Valo E
CW
Chen WM
OS
Onengut-Gumuscu S
RS
Rich SS
BE
Brennan EP
AD
Andrews D
KC
Kennedy C
GH
Gu HF
SL
Stechemesser L
WR
Weitgasser R
SJ
Sokolovska J
RL
Radzeviciene L
VR
Verkauskiene R
PN
Panduru NM
RP
Rossing P
AT
Ahluwalia TS
ZG
Zerbini G
MM
Marre M
HS
Hadjadj S
CT
Costacou T
MR
Miller RG
KB
Klein BE
LK
Lee KE
SJ
Snell-Bergeon JK
CM
Caramori ML
MM
Mauer M
BK
Brismar K
BP
Bjornstad P
MA
McKnight AJ
MG
McKay G
NV
Nair V
SR
Salem RM
GP
Groop PH
GC
Godson C
SK
Susztak K
KM
Kretzler M
MA
Maxwell AP
KA
Krolewski A
PA
Paterson A
SN
Sandholm-Lafferre N
FJ
Florez JC
HJ
Hirschhorn JN
Chapter II

Abstract

Summary of the research findings

Abstract Key Points: Comprehensive genome-wide association study of eGFR in diabetes, accounting for diabetes duration, kidney disease, and known modifiers, identified novel genetic effects.Incorporation of various kidney multi-omics data provides supporting evidence for the role of novel genome-wide association study loci in diabetic kidney disease. Background: Diabetic kidney disease (DKD) is a serious diabetes complication caused by both environmental and genetic risk factors. Previous genome-wide association studies (GWAS) have identified several loci associated with kidney function and kidney disease in the general population and, to a lesser extent, in diabetes. Methods: To uncover the genetic factors driving diabetes-induced kidney function, we conducted a series of GWAS meta-analyses of eGFR in 17,267 individuals with type 1 diabetes and 35,264 with type 2 diabetes (52,531 total), using multiple well-characterized cohorts of type 1 diabetes DKD and data from the UK Biobank and SUrrogate markers for Micro- and Macrovascular hard end points for Innovative diabetes Tools (SUMMIT) consortium. We further accounted for DKD case/control status, diabetes duration and subtype, body mass index, glycated hemoglobin levels, and the relationship between eGFR and albuminuria. Results: GWAS identified 13 loci associated with eGFR (P < 5×10−8), with five loci (candidate genes: HIPK3, TRIM5, RORA, ERBB4, and BCL6/LPP) not associated with or were in opposite directions as compared with eGFR in the general population. Four candidate genes (HIPK3, BCL6, LPP, and RORA) demonstrated evidence of differential expression in kidney compartments and cells among subgroups with DKD or diabetes versus controls. Lead single-nucleotide polymorphisms rs8027829 (RORA) and rs76300256 (BCL6/LPP) were methylation quantitative trait loci in whole blood and kidney tissue, respectively, and rs76300256 and its related CpGs all cluster in a kidney enhancer. Conclusions: Our integrated approach identified candidate genes with diabetes-specific effects on kidney function. Keywords: GFR; diabetic kidney disease; human genetics.

5,064 European ancestry individuals

Chapter III

Study Statistics

Key metrics and study information

5064
Total Participants
GWAS
Study Type
No
Replicated
European
Ancestry
Romania, Republic of Ireland, Canada, Austria, Latvia, Sweden, U.S., Finland, Denmark, Italy, U.K., Lithuania, France
Recruitment Country
Chapter IV

Analysis

Comprehensive review of health and genetic findings

Important Disclaimer: This review has been performed semi-automatically and is provided for informational purposes only. While we strive for accuracy, this analysis may contain errors, omissions, or misinterpretations of the original research. DNA Genics disclaims all liability for any inaccuracies, errors, or consequences arising from the use of this information. Users should independently verify all information and consult original research publications before making any decisions based on this content. This analysis is not intended as a substitute for professional scientific review or medical advice.

Analysis In Progress

Our analysis of this publication is currently being prepared. Please check back soon for comprehensive insights into the health and genetic findings discussed in this research.